How Participants Perceive Biomedical Research in Pulmonology
PROTOACCEPT2
1 other identifier
observational
500
1 country
2
Brief Summary
The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2018
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 5, 2018
CompletedFirst Posted
Study publicly available on registry
January 11, 2018
CompletedStudy Start
First participant enrolled
March 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedMarch 10, 2020
March 1, 2019
1.8 years
January 5, 2018
March 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The PROTOACCEPT2 questionnaire.
day 0 (transversal study)
Study Arms (1)
The study population
The target population corresponds to patients with a respiratory disease already included in a biomedical research protocol. Intervention: Questionnaire
Interventions
The Questionnaire is provided in the links at the end of the declaration.
Eligibility Criteria
The target population corresponds to patients with a respiratory disease already included in a biomedical research protocol.
You may qualify if:
- The patient presents with at least one of the following: (1) asthma, (2) chronic obstructive pulmonary disease, (3) bronchiectasis, (4) idiopathic pulmonary fibrosis, (5) pulmonary arterial hypertension, (6) sleep apnoea syndrome
- The patient is participating in a biomedical research protocol.
You may not qualify if:
- Patient under 18 years of age
- Patient judged incapable of filling out the questionnaire for linguistic or other reasons.
- The patient has already participated in the present study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
APHM - Hôpital Nord
Marseille, 13915, France
CHRU Montpellier - Hôpital Arnaud de Villeneuve
Montpellier, 34295, France
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Arnaud Bourdin, MD, PhD
University Hospitals of Montpellier
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 5, 2018
First Posted
January 11, 2018
Study Start
March 7, 2018
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
March 10, 2020
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Individual datasets will be made available at time of submission.
- Access Criteria
- The conditions under which members of the public will be granted access to the uploaded files are: * The user does not work for a private insurance company; * The data will be used/examined in a not-for-profit manner; * The data will not be used in an attempt to identify a patient or group of patients; * The data will not be used in support of any kind of private insurance policy or health penalties; * The data will be used/examined for the advancement of science/teaching while respecting participant/patient privacy and rights; * The user will state why they wish to access the data.
The general goal is to make the study data available to interested researchers as well as to provide proof of transparency for the study. Data (and an accompanying data dictionary) will be de-identified and potentially further cleaned or aggregated as the investigators deem necessary to protect participant anonymity. Data will be made available on a not-for-profit, free platform that allows access control: zenodo. A link on osf.io/pxnhc will point towards the zenodo upload.